These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

557 related items for PubMed ID: 26148131

  • 21. Prognostic impact of pancreatic margin status in the intraductal papillary mucinous neoplasms of the pancreas.
    Fujii T, Kato K, Kodera Y, Kanda M, Nagai S, Yamada S, Kanzaki A, Sugimoto H, Nomoto S, Takeda S, Morita S, Nakamura S, Nakao A.
    Surgery; 2010 Aug; 148(2):285-90. PubMed ID: 20434746
    [Abstract] [Full Text] [Related]

  • 22. Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas.
    Schnelldorfer T, Sarr MG, Nagorney DM, Zhang L, Smyrk TC, Qin R, Chari ST, Farnell MB.
    Arch Surg; 2008 Jul; 143(7):639-46; discussion 646. PubMed ID: 18645105
    [Abstract] [Full Text] [Related]

  • 23. Treatment strategy for main duct intraductal papillary mucinous neoplasms of the pancreas based on the assessment of recurrence in the remnant pancreas after resection: a retrospective review.
    Tamura K, Ohtsuka T, Ideno N, Aso T, Shindo K, Aishima S, Ohuchida K, Takahata S, Ushijima Y, Ito T, Oda Y, Mizumoto K, Tanaka M.
    Ann Surg; 2014 Feb; 259(2):360-8. PubMed ID: 23989056
    [Abstract] [Full Text] [Related]

  • 24. Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas.
    Chari ST, Yadav D, Smyrk TC, DiMagno EP, Miller LJ, Raimondo M, Clain JE, Norton IA, Pearson RK, Petersen BT, Wiersema MJ, Farnell MB, Sarr MG.
    Gastroenterology; 2002 Nov; 123(5):1500-7. PubMed ID: 12404225
    [Abstract] [Full Text] [Related]

  • 25. Minimally invasive intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic study of 104 intraductal papillary-mucinous neoplasms.
    Nara S, Shimada K, Kosuge T, Kanai Y, Hiraoka N.
    Am J Surg Pathol; 2008 Feb; 32(2):243-55. PubMed ID: 18223327
    [Abstract] [Full Text] [Related]

  • 26. Intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia is a risk factor for the subsequent development of pancreatic ductal adenocarcinoma.
    Rezaee N, Barbon C, Zaki A, He J, Salman B, Hruban RH, Cameron JL, Herman JM, Ahuja N, Lennon AM, Weiss MJ, Wood LD, Wolfgang CL.
    HPB (Oxford); 2016 Mar; 18(3):236-46. PubMed ID: 27017163
    [Abstract] [Full Text] [Related]

  • 27. Surgical strategy for main pancreatic duct-type intraductal papillary mucinous neoplasm of the pancreas.
    Kuroki T, Adachi T, Ono S, Tanaka T, Kitasato A, Takatsuki M, Eguchi S.
    Hepatogastroenterology; 2012 Mar; 59(120):2631-4. PubMed ID: 22534541
    [Abstract] [Full Text] [Related]

  • 28. Pancreatic resection for intraductal papillary mucinous neoplasm- a thirteen-year single center experience.
    Marsoner K, Haybaeck J, Csengeri D, Waha JE, Schagerl J, Langeder R, Mischinger HJ, Kornprat P.
    BMC Cancer; 2016 Nov 04; 16(1):844. PubMed ID: 27809876
    [Abstract] [Full Text] [Related]

  • 29. Intraductal papillary mucinous neoplasms of the pancreas--predictors of malignancy.
    Fan F, Lai EC, Xie F, Yang JM, Xu F, Kan T, Shen RX, Yang XY, Lau Wan Y, Wu MC.
    Hepatogastroenterology; 2010 Nov 04; 57(99-100):635-9. PubMed ID: 20698241
    [Abstract] [Full Text] [Related]

  • 30. Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection.
    Rodriguez JR, Salvia R, Crippa S, Warshaw AL, Bassi C, Falconi M, Thayer SP, Lauwers GY, Capelli P, Mino-Kenudson M, Razo O, McGrath D, Pederzoli P, Fernández-Del Castillo C.
    Gastroenterology; 2007 Jul 04; 133(1):72-9; quiz 309-10. PubMed ID: 17631133
    [Abstract] [Full Text] [Related]

  • 31. Surgical outcome of intraductal papillary mucinous neoplasms of the pancreas.
    Nakagohri T, Kinoshita T, Konishi M, Takahashi S, Gotohda N.
    Ann Surg Oncol; 2007 Nov 04; 14(11):3174-80. PubMed ID: 17694416
    [Abstract] [Full Text] [Related]

  • 32. Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma.
    Woo SM, Ryu JK, Lee SH, Yoo JW, Park JK, Kim YT, Yoon YB.
    Pancreas; 2008 Jan 04; 36(1):50-5. PubMed ID: 18192881
    [Abstract] [Full Text] [Related]

  • 33. Parenchyma-sparing pancreatectomy for presumed noninvasive intraductal papillary mucinous neoplasms of the pancreas.
    Sauvanet A, Gaujoux S, Blanc B, Couvelard A, Dokmak S, Vullierme MP, Ruszniewski P, Belghiti J, Lévy P.
    Ann Surg; 2014 Aug 04; 260(2):364-71. PubMed ID: 24646561
    [Abstract] [Full Text] [Related]

  • 34. Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma.
    Maire F, Hammel P, Terris B, Paye F, Scoazec JY, Cellier C, Barthet M, O'Toole D, Rufat P, Partensky C, Cuillerier E, Lévy P, Belghiti J, Ruszniewski P.
    Gut; 2002 Nov 04; 51(5):717-22. PubMed ID: 12377813
    [Abstract] [Full Text] [Related]

  • 35. Invasive carcinoma derived from intraductal papillary mucinous carcinoma of the pancreas.
    Nakagohri T, Konishi M, Inoue K, Tanizawa Y, Kinoshita T.
    Hepatogastroenterology; 2004 Nov 04; 51(59):1480-3. PubMed ID: 15362782
    [Abstract] [Full Text] [Related]

  • 36. Long-term surveillance is necessary after operative resection for intraductal papillary mucinous neoplasm of the pancreas.
    Hirono S, Kawai M, Okada K, Miyazawa M, Shimizu A, Kitahata Y, Ueno M, Yanagisawa A, Yamaue H.
    Surgery; 2016 Aug 04; 160(2):306-17. PubMed ID: 27236360
    [Abstract] [Full Text] [Related]

  • 37. Mural nodule in branch duct-type intraductal papillary mucinous neoplasms of the pancreas is a marker of malignant transformation and indication for surgery.
    Akita H, Takeda Y, Hoshino H, Wada H, Kobayashi S, Marubashi S, Eguchi H, Tanemura M, Mori M, Doki Y, Nagano H.
    Am J Surg; 2011 Aug 04; 202(2):214-9. PubMed ID: 21376305
    [Abstract] [Full Text] [Related]

  • 38. Evaluation of surgical resection for pancreatic carcinoma at a Japanese single cancer institute.
    Nanashima A, Tobinaga S, Abo T, Hatano K, Takeshita H, Nonaka T, Hidaka S, Tanaka K, Kunizaki M, Sawai T, Yasutake T, Nagayasu T.
    Hepatogastroenterology; 2012 May 04; 59(115):911-5. PubMed ID: 22469741
    [Abstract] [Full Text] [Related]

  • 39. Outcomes of nonresected main-duct intraductal papillary mucinous neoplasms of the pancreas.
    Daudé M, Muscari F, Buscail C, Carrère N, Otal P, Selves J, Buscail L, Bournet B.
    World J Gastroenterol; 2015 Mar 07; 21(9):2658-67. PubMed ID: 25759534
    [Abstract] [Full Text] [Related]

  • 40. Intraductal papillary mucinous neoplasms of the pancreas: clinicopathological features and long term outcome related to histopathological group.
    De Moor V, Arvanitakis M, Nagy N, Coppens E, Delhaye M, Closset J.
    Hepatogastroenterology; 2012 Mar 07; 59(114):565-9. PubMed ID: 22353525
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.